文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

肥胖患者同期行食管裂孔疝修补与胃旁路术的疗效分析

Concurrent hiatal hernia repair and gastric bypass as an adjunct in the treatment of hiatal hernia in populations with obesity.
PubMed 文献 · Surg Endosc · 2025-06-16

围术期干预性并发症1例(2%),5年烧心/反流缓解率59%,糖尿病和高血压分别改善80%和75%。原发手术5年BMI变化-11.5 kg/m2,%TWL 37.7%。

要点

  • 同期RYGB与HHR在肥胖患者中安全,围术期干预性并发症仅2%。
  • 5年烧心/反流缓解率59%,糖尿病和高血压改善率分别为80%和75%。
  • 原发手术5年减重显著,BMI变化-11.5 kg/m2,%TWL 37.7%。

核心结论

  • 肥胖患者单纯食管裂孔疝修补耐久性差,同期RYGB安全有效,可治疗GERD并改善肥胖相关共病。

主要发现

  • 围术期需干预并发症1例(2%),因口服不耐受非计划再入院3例(4%),边缘溃疡治疗4例(8%)。
  • 烧心/反流症状缓解率1年86%、3年70%、5年59%。
  • 5年糖尿病改善80%、高血压改善75%、高脂血症改善33%。
  • 原发手术5年BMI变化-11.5 kg/m2,%TWL 37.7%;修正手术BMI变化-2.4 kg/m2,%TWL 3.6%。

临床怎么用

  • 对肥胖合并食管裂孔疝患者,可考虑同期行RYGB与HHR,以降低复发并改善代谢共病。
  • 术后需关注口服不耐受和边缘溃疡,并长期随访反流症状及共病改善情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive hiatal hernia repair with fundoplication (HHR) is the standard of care for hiatal hernias but has a high risk of recurrence even in populations without obesity. Concomitant roux-en-y gastric bypass (RYGB) with HHR may mitigate the increased risk of hiatal hernia recurrence in patients with obesity while also addressing obesity-related comorbidities. There is a paucity of data on this procedure. It is hypothesized that a concomitant RYGB with HHR is safe and effective in patients with obesity. METHODS: This is a single institution retrospective review of adult patients who underwent concomitant RYGB with HHR from 2014-2023. Patient charts were reviewed to collect data on complications, weight loss, GERD symptom resolution, and improvement in other obesity-related comorbidities. Outcomes were measured at one-, three-, and five-year follow-up. RESULTS: Sixty-four patients met inclusion criteria. Fifty-three patients had primary and eleven patients had revisional surgery. There was one (2%) perioperative complication that required intervention, three (4%) unplanned readmissions for PO intolerance, and four patients (8%) treated for marginal ulcer. Resolution of heartburn/reflux symptoms was 86% at one year, 70% at 3 year, and 59% at 5 year follow-up. Improvement in diabetes (80%), hypertension (75%), and hyperlipidemia (33%) were noted at 5 years. The change in BMI and %TWL at 5 years for primary procedures was -11.5 kg/m2 and 37.7%, respectively. For revisional procedures, change in BMI was -2.4 kg/m2 and %TWL was 3.6%. CONCLUSION: Durability of a HHR in the setting of obesity is poor. Concomitant RYGB with HHR is safe and effective for treating GERD while also improving obesity and obesity-associated comorbidities.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Siegel L, Carroll R, Thompson DT, et al. Concurrent hiatal hernia repair and gastric bypass as an adjunct in the treatment of hiatal hernia in populations with obesity. Surg Endosc. 2025. PMID: 40523974. doi:10.1007/s00464-025-11854-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。